Congenital anaemia associated with loss-of-function variants in DNA polymerase epsilon 1

J Med Genet. 2024 Feb 21;61(3):239-243. doi: 10.1136/jmg-2023-109444.

Abstract

DNA polymerase epsilon (Pol ε), a component of the core replisome, is involved in DNA replication. Although genetic defects of Pol ε have been reported to cause immunodeficiency syndromes, its role in haematopoiesis remains unknown. Here, we identified compound heterozygous variants (p.[Asp1131fs];[Thr1891del]) in POLE, encoding Pol ε catalytic subunit A (POLE1), in siblings with a syndromic form of severe congenital transfusion-dependent anaemia. In contrast to Diamond-Blackfan anaemia, marked reticulocytopenia or marked erythroid hypoplasia was not found. Their bone marrow aspirates during infancy revealed erythroid dysplasia with strongly positive TP53 in immunostaining. Repetitive examinations demonstrated trilineage myelodysplasia within 2 years from birth. They had short stature and facial dysmorphism. HEK293 cell-based expression experiments and analyses of patient-derived induced pluripotent stem cells (iPSCs) disclosed a reduced mRNA level of Asp1131fs-POLE1 and defective nuclear translocation of Thr1891del-POLE1. Analysis of iPSCs showed compensatory mRNA upregulation of the other replisome components and increase of the TP53 protein, both suggesting dysfunction of the replisome. We created Pole-knockout medaka fish and found that heterozygous fishes were viable, but with decreased RBCs. Our observations expand the phenotypic spectrum of the Pol ε defect in humans, additionally providing unique evidence linking Pol ε to haematopoiesis.

Keywords: Anemia; Bone Marrow Diseases; Genetic Diseases, Inborn; Genomic Instability; Pediatrics.

MeSH terms

  • Animals
  • DNA Polymerase II* / genetics
  • DNA Polymerase II* / metabolism
  • DNA Replication* / genetics
  • HEK293 Cells
  • Humans
  • RNA, Messenger
  • Tumor Suppressor Protein p53 / genetics

Substances

  • DNA Polymerase II
  • Tumor Suppressor Protein p53
  • RNA, Messenger